SHAREHOLDER ALERT: Barr Law Group Investigating the Officers and Directors of NGHC, GOCO, PSTX, and PROG; Shareholders are Encouraged to Contact the Firm
03 sept. 2020 09h00 HE
|
Barr Law Group
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- If you own any of the above stocks and would like to discuss your legal rights, please email leo@barrlaw.com or call (619) 400-4966. ...
POSEIDA THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating Poseida Therapeutics, Inc. on Behalf of Poseida Stockholders and Encourages Investors to Contact the Firm
01 sept. 2020 16h09 HE
|
Bragar Eagel & Squire
NEW YORK, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Poseida Therapeutics,...
Poseida Therapeutics Presents Preclinical Data Demonstrating Multiple Therapeutic Advantages from BCMA-Specific CAR-T Program at American Association for Cancer Research Annual Meeting
04 avr. 2017 08h00 HE
|
Poseida Therapeutics, Inc.
SAN DIEGO, April 04, 2017 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, today...
Poseida Therapeutics Appoints Debra Gessner as Vice President, Regulatory Affairs
03 janv. 2017 09h00 HE
|
Poseida Therapeutics, Inc.
SAN DIEGO, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, today announced...
Poseida Therapeutics to Present Three Abstracts on Novel BCMA-Specific CAR-T Therapy at American Society of Hematology 2016 Annual Meeting
03 nov. 2016 09h00 HE
|
Poseida Therapeutics, Inc.
SAN DIEGO, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, today...
Poseida Therapeutics Establishes Scientific Advisory Board
08 sept. 2016 07h30 HE
|
Poseida Therapeutics, Inc.
SAN DIEGO, Sept. 08, 2016 (GLOBE NEWSWIRE) -- Poseida Therapeutics, Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics,...
Poseida Therapeutics Expands Executive Leadership Team
18 août 2016 07h30 HE
|
Poseida Therapeutics, Inc.
SAN DIEGO, Aug. 18, 2016 (GLOBE NEWSWIRE) -- Poseida Therapeutics, Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics,...